Intermetatarsal Bursitis in Patients With Rheumatoid Arthritis
NCT05698563 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 3
Last updated 2025-09-22
Summary
The aim of the study is to investigate the incidence and clinical implications of intermetatarsal bursitis (IMB) in patients with rheumatoid arthritis (RA).
The hypothesis is that IMB is a cause of pain in patients with RA.
Conditions
- Intermetatarsal Bursitis
- Rheumatoid Arthritis
Interventions
- DIAGNOSTIC_TEST
-
Magnetic resonance imaging
MRI scan with contrast of the foot or feet
- DIAGNOSTIC_TEST
-
Ultrasound
Ultrasound scan of the feet
- DRUG
-
Corticosteroid injection
Administered ultrasound guided to patients with intermetatarsal bursitis
- OTHER
-
Clinical foot evaluation
An examination of the feet
- OTHER
-
Picture of the feet
To evaluate the presence of V-sign/spreading toes
Sponsors & Collaborators
-
The Danish Rheumatism Association
collaborator OTHER -
Rigshospitalet, Denmark
lead OTHER
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- DIAGNOSTIC
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-01-18
- Primary Completion
- 2023-02-14
- Completion
- 2024-12-12
Countries
- Denmark
Study Locations
More Related Trials
-
A Study to Evaluate the Effectiveness of Infliximab and Changes in Hand and Wrist Magnetic Resonance Imaging (MRI) in Participants With Active Rheumatoid Arthritis (RA) (P08136)
NCT01313520 ·Status: COMPLETED ·Phase: PHASE2
-
The Effect of Certolizumab Pegol on MRI Synovitis and Bone Edema in Rheumatoid Arthritis Patients
NCT01213017 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of RoActemra/Actemra (Tocilizumab) in Combination With DMARDs Versus Current Best Practice DMARD Therapy in Patients With Rheumatoid Arthritis
NCT01251120 ·Status: TERMINATED ·Phase: PHASE4
-
Treatment of TNFa Naive Patients With Poor Prognosis Rheumatoid Arthritis
NCT00963703 ·Status: COMPLETED ·Phase: NA
-
Certolizumab and Lower Extremity Lymph Flow in Rheumatoid Arthritis (RA)
NCT01098201 ·Status: COMPLETED
-
Research Study on the Immunosuppressive Effects of a Cell Therapy Product on PBMC Isolated From Blood of Patients With Inflammatory Rheumatic Diseases
NCT03454932 ·Status: TERMINATED
-
Rheumatoid Arthritis (DMARD) Intervention and UtilizationStudy
NCT00116714 ·Status: COMPLETED
-
Changes in Ultrasonographic Assessment of Inflammation Upon Initiation of Adalimumab Combination Therapy in Chinese Rheumatoid Arthritis (RA) Patients With Inadequate Response to Methotrexate
NCT02786563 ·Status: WITHDRAWN
-
A Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Certolizumab Pegol in Combination With Methotrexate in the Treatment of Disease Modifying Antirheumatic Drugs (DMARD)-naïve Adults With Early Active Rheumatoid Arthritis
NCT01519791 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy of Remicade in the Treatment of Active Rheumatoid Arthritis Despite Methotrexate (Study P03027)
NCT00794898 ·Status: COMPLETED ·Phase: PHASE4
-
A Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Certolizumab Pegol in Combination With Methotrexate in the Treatment of Disease Modifying Antirheumatic Drugs (DMARD)-naïve Adults With Early Active Rheumatoid Arthritis
NCT01521923 ·Status: COMPLETED ·Phase: PHASE3
-
Aiming for Remission in Rheumatoid Arthritis (RA) - the ARCTIC Trial
NCT01205854 ·Status: COMPLETED ·Phase: PHASE4
-
Study of Abatacept (BMS-188667) in Subjects With Active Rheumatoid Arthritis on Background Non-biologic DMARDS (Disease Modifying Antirheumatic Drugs) Who Have an Inadequate Response to Anti-TNF Therapy
NCT00124982 ·Status: COMPLETED ·Phase: PHASE3
-
Targeted Ultrasound in Rheumatoid Arthritis
NCT02056184 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Evaluate the Efficacy, Safety, and Tolerability of IMVT-1402 in Adult Participants With Active, Difficult to Treat Rheumatoid Arthritis
NCT06754462 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
A Study of JNJ-67484703 in Participants With Active Rheumatoid Arthritis
NCT04985812 ·Status: COMPLETED ·Phase: PHASE1
-
Cimzia Treatment in Rheumatoid Arthritis: Randomizing to Stop Versus Continue Disease-modifying Anti-rheumatic Drug(s)
NCT01489384 ·Status: UNKNOWN
-
Phase III Study of BMS-188667 (CTLA4Ig) in Patients With Rheumatoid Arthritis Who Are Currently Failing Anti-TNF Therapy or Who Have Failed Anti-TNF Therapy in the Past.
NCT00048581 ·Status: COMPLETED ·Phase: PHASE3
-
Pain Modulation in Rheumatoid Arthritis (RA) - Influence of Adalimumab
NCT01197144 ·Status: COMPLETED ·Phase: NA
-
COVID-19 Vaccination in Rheumatic Disease Patients
NCT04839315 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
The Effect of Adalimumab Plus Methotrexate (MTX) Versus Placebo Plus MTX on Cartilage in (RA) Patients
NCT02150473 ·Status: TERMINATED ·Phase: PHASE3
-
Multiple Ascending Doses of Rozibafusp Alfa (AMG 570) in Adults With Rheumatoid Arthritis
NCT03156023 ·Status: COMPLETED ·Phase: PHASE1
-
Infliximab and Classic DMARDs in the Rheumatoid Arthritis Patients
NCT01915537 ·Status: UNKNOWN ·Phase: NA
-
A Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in Combination With a DMARD in Patients With Active Rheumatoid Arthritis
NCT01225393 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of the Efficacy and Safety of TACI-antibody Fusion Protein Injection (RC18) in Subjects With Inadequate Response to TNF-α Antagonists Due to Treat Moderate and Severe Rheumatoid Arthritis
NCT02882087 ·Status: TERMINATED ·Phase: PHASE2